
Merck
North America, New Jersey, United States, Rahway
Description
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Investor Profile
Merck has made 24 investments, with 3 in the past 12 months and 25% as lead.
Stage Focus
- Series A (29%)
- Series Unknown (13%)
- Seed (13%)
- Series E (8%)
- Series B (8%)
- Post Ipo Equity (8%)
- Series D (4%)
- Private Equity (4%)
- Series C (4%)
- Grant (4%)
Country Focus
- United States (63%)
- China (8%)
- Austria (4%)
- Mexico (4%)
- India (4%)
- Canada (4%)
- Switzerland (4%)
- United Kingdom (4%)
- Thailand (4%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Pharmaceutical
- Genetics
- Health Diagnostics
- Information Technology
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.